Lexaria Bioscience Corp. (LEXX) stock: key figures, P/E, revenue and dividend
Health Care · Canada · ISIN US52886N4060
Lexaria Bioscience Corp. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 705,923.00 USD |
| Gross profit | 703,203.00 USD |
| Operating income | -11.88 m USD |
| EBIT | -11.91 m USD |
| Net income | -11.90 m USD |
| Diluted EPS – continuing operations | -0.66 USD |
Full history since 2005, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company's DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
More stocks
- Lifeloc Technologies, Inc (LCTC)
- Newton Golf Company, Inc. (NWTG)
- GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES (GWTI)
- CHICAGO RIVET & MACHINE CO (CVR)
- Bryn Inc. (BRRN)
- Volato Group, Inc. (SOAR)
- BT Brands, Inc. (BTBD)
- Caring Brands, Inc. (CABR)
- AVALON HOLDINGS CORP (AWX)
- Foxx Development Holdings Inc. (FOXX)
- TEN Holdings, Inc. (XHLD)
- Phio Pharmaceuticals Corp. (PHIO)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.